Evidence map›Paper›PMID 29622625›Full record

ArticleStroke2018

Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.

Anil Can, Victor M Castro, Dmitriy Dligach, Sean Finan, Sheng Yu, Vivian Gainer, Nancy A Shadick, Guergana Savova, Shawn Murphy, Tianxi Cai and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Stroke, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Anil CanFrom the Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.C., R.D.).
Victor M CastroResearch Information Systems and Computing, Partners Healthcare, Boston, MA (V.M.C., V.G., S.M.
Dmitriy DligachBoston Children's Hospital Informatics Program, MA (D.D., S.F., G.S.).
Sean FinanBoston Children's Hospital Informatics Program, MA (D.D., S.F., G.S.).
Sheng YuDepartment of Medicine, Brigham and Women's Hospital, Boston, MA (S.Y., S.T.W.).
Vivian GainerResearch Information Systems and Computing, Partners Healthcare, Boston, MA (V.M.C., V.G., S.M.
Nancy A ShadickDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA (N.A.S.).
Guergana SavovaBoston Children's Hospital Informatics Program, MA (D.D., S.F., G.S.).
Shawn MurphyResearch Information Systems and Computing, Partners Healthcare, Boston, MA (V.M.C., V.G., S.M.
Tianxi CaiBiostatistics, Harvard T. H. Chan School of Public Health, Boston, MA (T.C.).
Scott T WeissDepartment of Medicine, Brigham and Women's Hospital, Boston, MA (S.Y., S.T.W.).
Rose DuFrom the Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.C., R.D.) rdu@bwh.harvard.edu.
Boston Children's Hospital · USBrigham and Women's Hospital · USHarvard University · USMassachusetts General Hospital · USTsinghua University · CN

Funding

TrainingU54HG007963 · NHGRI · HARVARD MEDICAL SCHOOL · PI KOHANE, ISAAC S. · 2014 to 2018
$18.3M
Finding Genomic Profiles of COVID-19 Phenotypes from the EHRU01HG008685 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIZABETH W KARLSON, Matthew S Lebo · 2015 to 2026
$13.6M
Developing i2b2 into a Health Innovation Platform for Clinical Decision Support in the Genomics EraR01HG009174 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI ARONSON, SAMUEL JEFFREY, MACRAE, CALUM A. · 2016 to 2019
$2.9M
NHGRI NIH HHS R01 HG009174NHGRI NIH HHS U01 HG008685NHGRI NIH HHS U54 HG007963
6 · The paper itself

Abstract

background and purposeGrowing evidence from experimental animal models and clinical studies suggests the protective effect of statin use against rupture of intracranial aneurysms; however, results from large studies detailing the relationship between intracranial aneurysm rupture and total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and lipid-lowering agent use are lacking.

methodsThe medical records of 4701 patients with 6411 intracranial aneurysms diagnosed at the Massachusetts General Hospital and the Brigham and Women's Hospital between 1990 and 2016 were reviewed and analyzed. Patients were separated into ruptured and nonruptured groups. Univariable and multivariable logistic regression analyses were performed to determine the effects of lipids (total cholesterol, LDL, and HDL) and lipid-lowering medications on intracranial aneurysm rupture risk. Propensity score weighting was used to account for differences in baseline characteristics of the cohorts.

resultsLipid-lowering agent use was significantly inversely associated with rupture status (odds ratio, 0.58; 95% confidence interval, 0.47-0.71). In a subgroup analysis of complete cases that includes both lipid-lowering agent use and lipid values, higher HDL levels (odds ratio, 0.95; 95% confidence interval, 0.93-0.98) and lipid-lowering agent use (odds ratio, 0.41; 95% confidence interval, 0.23-0.73) were both significantly and inversely associated with rupture status, whereas total cholesterol and LDL levels were not significant. A monotonic exposure-response curve between HDL levels and risk of aneurysmal rupture was obtained.

conclusionsHigher HDL values and the use of lipid-lowering agents are significantly inversely associated with ruptured intracranial aneurysms.

Indexed as

AdultAgedAneurysm, RupturedBenzimidazolesCholesterol, HDLCholesterol, LDLCholestyramine ResinColestipolEzetimibeFemaleFibric AcidsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsIntracranial AneurysmLogistic ModelsBenzimidazolesBMS201038Cholesterol, HDLCholesterol, LDLCholestyramine ResinColestipolEzetimibeFibric AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsmipomersenOligonucleotidesPCSK9 Inhibitorsaneurysmcholesterolintracranial aneurysmslipidssubarachnoid hemorrhage

Identifiers

PMID29622625
PMCPMC5915939
OpenAlexW2796299018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.